| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |